Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Non Operating Interest Expenses (2009 - 2026)

Updated

Abvc Biopharma (ABVC) reported Non Operating Interest Expenses of $43,649 for Q3 2026, up 41.0% from $30,959 a year earlier and up 3.1% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Abvc Biopharma's Non Operating Interest Expenses came in at $167,900, down 72.0% year-over-year; for FY2025, it came in at $415,890, down 49.6% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
  • By year, Non Operating Interest Expenses came in at $825,899 in FY2024 (-37.1%), $1.31 million in FY2023 (+346.9%), $293,968 in FY2022 (+29.4%) and $227,210 in FY2021 (-43.9%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of -$76,368 in Q4 2023 and a high of $1.22 million in Q3 2023.
  • Year over year, Non Operating Interest Expenses gained in two of the last seven quarters, with an average decline of 41.4%.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2023 (growth of 863.1%); the low point was Q1 2022 (a decline of 86.0%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $42,323 (Q2 2026), $49,377 (Q1 2026) and $32,551 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 217.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Abvc Biopharma 24.28 Mn 21.86 Mn - 43,649.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 43,649.00
Jun 30, 2026 42,323.00
Mar 31, 2026 49,377.00
Dec 31, 2025 32,551.00
Sep 30, 2025 30,959.00
Jun 30, 2025 129,413.00
Mar 31, 2025 222,967.00
Dec 31, 2024 216,715.00
Sep 30, 2024 220,429.00
Jun 30, 2024 207,079.00
Mar 31, 2024 181,676.00
Dec 31, 2023 -76,368.00
Sep 30, 2023 1.22 Mn
Jun 30, 2023 114,752.00
Mar 31, 2023 56,663.00
Dec 31, 2022 134,461.00
Sep 30, 2022 126,536.00
Jun 30, 2022 14,758.00
Mar 31, 2022 18,213.00
Dec 31, 2021 -24,367.00
API Access

Abvc Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY